vVARDIS
PrivateLast Round
IPO
Nov 6, 2026
Est. Valuation
$4.1B
Momentum
Top 1%
of companies Caplight tracks
Company Overview
vVARDIS operates in Healthcare & Life Sciences and is based in Zug. Its latest recorded funding round was a Private Equity round in April 2026.
vVARDIS is a Swiss healthcare company that develops and manufactures biomimetic, non-invasive dental products for professionals designed for the drill-free treatment of early tooth decay.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Home & Lifestyle
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
vVARDIS Comparables
Compare vVARDIS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DMG Chemisch-Pharmazeutische Fabrik GmbH | 80% | |
| Elevate Oral Care | 80% | |
| Solventum Corp. | 79% |
For institutional investors. Book with your work email.
vVARDIS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Nov 6, 2026 | ||||
| Private Equity | Apr 27, 2026 | ||||
| VC Round | Jul 15, 2025 | ||||
| VC Round | Feb 11, 2025 | ||||
| Private Equity | Mar 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
vVARDIS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | VC Round |
| EMZ Partners | Private Equity |
| Apollo Global Management | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2026
Reported a net loss of $52.20 million prior to IPO announcement.
- Nov 9, 2026
$49.68 million in revenue prior to IPO announcement.
For institutional investors. Book with your work email.
vVARDIS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about vVARDIS's valuation, stock price, and market status.
Is vVARDIS a public or private company?
vVARDIS is a private company.
What is the current stock price of vVARDIS?
vVARDIS is a private company, so its shares have no public market price. Caplight tracks vVARDIS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is vVARDIS worth (valuation)?
vVARDIS's valuation is estimated at $4.1B based on funding round data.
Can I buy vVARDIS stock?
vVARDIS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was vVARDIS's last funding round?
vVARDIS's most recent funding round was IPO on November 6, 2026.
Who are the main investors in vVARDIS?
Key investors in vVARDIS include OrbiMed, Apollo Global Management.
Will vVARDIS IPO soon?
No public IPO plans have been announced for vVARDIS.
How can I track vVARDIS secondary market activity?
Caplight tracks bids, offers, and trades in vVARDIS's shares on secondary markets.